Pro-Pharmaceuticals, Inc. (OTC: PRWP) today announced that it has changed its name to Galectin Therapeutics Inc. to more accurately reflect the Company’s core expertise in galectin science and its leading platform for the creation of galectin inhibitors to treat serious diseases including fibrosis and cancer. The name change was implemented by Galectin Therapeutics' Board of Directors pursuant to authorization by the Company’s shareholders in a vote recorded at the Annual Stockholders Meeting on May 26, 2011. Galectin Therapeutics’ stock will continue to trade under the symbol “PRWP” but the Company anticipates that it will begin trading under a new ticker symbol in the near future.
